Metformin (500mg)
Danavish Metformin+Voglibose 500mg/0.2mg Tablet SR is a combination antidiabetic medication containing metformin hydrochloride and voglibose. This sustained-release formulation belongs to the class of glucose-lowering agents, with metformin being a biguanide and voglibose an alpha-glucosidase inhibitor. Available in strip packs of 10 tablets, this medicine attracts 5% GST under HSN code 3004 in India as a pharmaceutical preparation.
The following medicines contain the same active ingredient (Metformin (500mg)) and may be offered by pharmacists as substitutes. Actual substitute selection depends on availability at your pharmacy and prescribing doctor's instructions.
Look any other medicine up the same way:
Metformin+Voglibose combination tablets attract 5% GST under HSN code 3004, which covers medicaments for therapeutic or prophylactic uses, put up in measured doses or in forms for retail sale.
Danavish Metformin+Voglibose 500mg/0.2mg Tablet SR is a Schedule H medicine and requires a prescription from a registered medical practitioner. Confirm against the current Schedule H, H1 and X lists notified in the Gazette of India before dispensing.
Common brand variants of this combination in India may include Voglimac-M, Diabend-MV, Metgli-V, and Glucobay-M among others, though availability may vary across different manufacturers and regions.
Nesayo tracks your stock, flags near-expiry, and auto-orders from your distributor when you run low.
Start free →This page is informational only. Pricing and availability vary by pharmacy, location, and time. Verify current MRP on the printed package before sale. Consult a registered physician or pharmacist for medical advice. Nesayo is not a medical device and does not provide clinical decision support.